Fabry disease is an X-linked inherited lysosomal disorder that causes accumulation of
glycosphingolipids in body fluids and tissues, leading to progressive organ damage and …

Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by
deficient activity of the enzyme alpha-galactosidase. While AFD is recognized as a …

Fabry disease (FD) is a lysosomal storage disorder due to the impaired activity of the α-
galactosidase A (GLA) enzyme which induces Gb3 deposition and multiorgan dysfunction …

Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular
involvement, whose presence is a major determinant of adverse clinical outcomes. As a …

As a slowly progressive form of hypertrophic cardiomyopathy (HCM), Anderson-Fabry
disease (FD) resembles the phenotype of the most common sarcomeric forms, although …

Cardiovascular involvement is common in Fabry's disease and is the leading cause of
morbidity and mortality. The research is focused on identifying diagnostic clues suggestive …

Background: Hypertrophic cardiomyopathy (HCM) and Fabry disease (FD) are genetically
inherited diseases with left ventricular hypertrophy (LVH) phenotype characteristics that …

Purpose To perform a systematic review and meta-analysis to assess the effect of enzyme
replacement therapy on cardiac MRI parameters in patients with Fabry disease. Materials …

Fabry disease (FD) is an X-linked disorder with α-galactosidase A deficiency. Males (> 30
years) and females (> 40 years) often present with cardiac manifestations, predominantly left …

Aims Cardiac left ventricular hypertrophy (LVH) is the most common manifestation of heart
involvement in Anderson–Fabry disease (AFD). Conventional cardiac imaging is not …